Literature DB >> 11927610

Mixed signals in heart failure: cancer rules.

Masahiko Hoshijima1, Kenneth R Chien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11927610      PMCID： PMC150934          DOI： 10.1172/JCI15380

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  48 in total

Review 1.  Genetics of heart development.

Authors:  J N Chen; M C Fishman
Journal:  Trends Genet       Date:  2000-09       Impact factor: 11.639

2.  Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation.

Authors:  Y Hiroi; S Kudoh; K Monzen; Y Ikeda; Y Yazaki; R Nagai; I Komuro
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

3.  Cardiac gene delivery with cardiopulmonary bypass.

Authors:  M J Davidson; J M Jones; S M Emani; K H Wilson; J Jaggers; W J Koch; C A Milano
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

4.  Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy.

Authors:  Y Zou; Y Hiroi; H Uozumi; E Takimoto; H Toko; W Zhu; S Kudoh; M Mizukami; M Shimoyama; F Shibasaki; R Nagai; Y Yazaki; I Komuro
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

5.  Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor.

Authors:  D Wang; P S Chang; Z Wang; L Sutherland; J A Richardson; E Small; P A Krieg; E N Olson
Journal:  Cell       Date:  2001-06-29       Impact factor: 41.582

6.  Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.

Authors:  M H Gollob; M S Green; A S Tang; T Gollob; A Karibe; A S Ali Hassan ; F Ahmad; R Lozado; G Shah; L Fananapazir; L L Bachinski; R Roberts; A S Hassan
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

7.  Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes.

Authors:  N Wettschureck; H Rütten; A Zywietz; D Gehring; T M Wilkie; J Chen; K R Chien; S Offermanns
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

8.  A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease.

Authors:  B G Bruneau; G Nemer; J P Schmitt; F Charron; L Robitaille; S Caron; D A Conner; M Gessler; M Nemer; C E Seidman; J G Seidman
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

9.  CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.

Authors:  R Passier; H Zeng; N Frey; F J Naya; R L Nicol; T A McKinsey; P Overbeek; J A Richardson; S R Grant; E N Olson
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 10.  Abnormalities of calcium cycling in the hypertrophied and failing heart.

Authors:  S R Houser; V Piacentino; J Weisser
Journal:  J Mol Cell Cardiol       Date:  2000-09       Impact factor: 5.000
View more
  40 in total

1.  Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies.

Authors:  Kenneth R Chien
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.

Authors:  Mauro Sbroggiò; Daniela Carnevale; Alessandro Bertero; Giuseppe Cifelli; Emanuele De Blasio; Giada Mascio; Emilio Hirsch; Wadie F Bahou; Emilia Turco; Lorenzo Silengo; Mara Brancaccio; Giuseppe Lembo; Guido Tarone
Journal:  Cardiovasc Res       Date:  2011-04-14       Impact factor: 10.787

Review 3.  Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures.

Authors:  Masahiko Hoshijima
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-04       Impact factor: 4.733

4.  HDACs and hypertrophy, kinases and cancer.

Authors:  Berdymammet Hojayev; Joseph A Hill
Journal:  Circulation       Date:  2011-05-16       Impact factor: 29.690

5.  Desmin modifications associate with amyloid-like oligomers deposition in heart failure.

Authors:  Giulio Agnetti; Victoria L Halperin; Jonathan A Kirk; Khalid Chakir; Yurong Guo; Linda Lund; Francesco Nicolini; Tiziano Gherli; Carlo Guarnieri; Claudio M Caldarera; Gordon F Tomaselli; David A Kass; Jennifer E Van Eyk
Journal:  Cardiovasc Res       Date:  2014-01-09       Impact factor: 10.787

6.  Gene coexpression network topology of cardiac development, hypertrophy, and failure.

Authors:  Frederick E Dewey; Marco V Perez; Matthew T Wheeler; Clifton Watt; Joshua Spin; Peter Langfelder; Steve Horvath; Sridhar Hannenhalli; Thomas P Cappola; Euan A Ashley
Journal:  Circ Cardiovasc Genet       Date:  2010-12-02

Review 7.  Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.

Authors:  Sabzali Javadov; Sehwan Jang; Bryan Agostini
Journal:  Pharmacol Ther       Date:  2014-06-09       Impact factor: 12.310

8.  Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function.

Authors:  Francine Côté; Etienne Thévenot; Cécile Fligny; Yves Fromes; Michèle Darmon; Marie-Anne Ripoche; Elisa Bayard; Naima Hanoun; Francoise Saurini; Philippe Lechat; Luisa Dandolo; Michel Hamon; Jacques Mallet; Guilan Vodjdani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

9.  Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.

Authors:  Ichiro Shiojima; Kaori Sato; Yasuhiro Izumiya; Stephan Schiekofer; Masahiro Ito; Ronglih Liao; Wilson S Colucci; Kenneth Walsh
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 10.  Emerging roles of junctophilin-2 in the heart and implications for cardiac diseases.

Authors:  David L Beavers; Andrew P Landstrom; David Y Chiang; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2014-06-15       Impact factor: 10.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.